Remedy Entertainment Oyj (REMEDY) fair value: what the stock is really worth
As of Sep 29, 2026: fair value of Remedy Entertainment Oyj €2.23, price €18.78, upside -88.1%, quality 51 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Structural break:
The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.
Stretched ValuationStrong overvaluation with only moderate quality.
!Fair value €2.23 · Strongly overvalued (−88.1%)
!Quality 51/100
!Mixed Growth(revenue 5y +7.7 %/yr)
!Loss-making · -22.2% net margin (TTM)
✓Low debt · generates free cash flow
!Trails peers(1/11)
!Narrow moat22/100
!Insider activity40/100
!Evidence only low, so the estimate is less certain
Watch Remedy Entertainment Oyj for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range €11.10 – €45.58 · fair‑value band €1.24 – €4.05 · the €18.78 price screens above the €2.23 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 27, 2026.
Follow Remedy Entertainment in your weekly email
Every Wednesday you see whether Remedy Entertainment is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Remedy Entertainment Oyj, a video game company, engages in the development and sale of PC and console games in Finland. It primarily creates story-driven and action games. The company also offers franchises under the Control, Alan Wake, and Max Payne brand names. Remedy Entertainment Oyj was incorporated in 1995 and is headquartered in Espoo, Finland.
Stock analysis
Remedy Entertainment Oyj (REMEDY) currently trades at €18.78, while our model-based Fair Value estimate is €2.23, 88.1% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of €2.79 per share, and 0 of the 10 models we run sit above the €18.78 price.
Bear case: the Multiples group reads lowest at €0.2500, and 10 of the 10 models stay below the price. Evidence for this calculation is low.
Scenario range: €1.24 (bear) to €4.05 (bull), the price of €18.78 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 51/100 (solid quality), in the Communication Services sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Remedy Entertainment Oyj reported revenue of €59.5M in FY2025 versus €44.7M in FY2021, a compound +7.4%/yr. Reported net income was −€13.0M in FY2025.
Key figures
Market cap €256M · P/S ratio 3.44 · EPS (TTM) €−0.9600 · Net margin −21.9% · Return on equity −20.6% · Return on assets (EBIT) −6.9% · Operating margin 7.8% · Revenue (TTM) €59.3M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 6% below its 52-week high and 69% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Communication Services peers we cover trades at 44% fair-value upside, at −88%, REMEDY screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (€0.2500 to €3.99). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear €1.24Fair Value €2.23Bull €4.05
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.47/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+17.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.7%
Start year 2020 (pandemic). Over 10 years: +15.8% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
32.2% (2020) → −7.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
more than +80 %
Yearly growth needed for the next five years to justify today's price.
Compare Remedy Entertainment Oyj with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronic Gaming & Multimedia · 143 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Remedy Entertainment Oyj Fair Value". https://www.fairvalue-calculator.com/stock/REMEDY
Frequently asked questions
Is Remedy Entertainment Oyj (REMEDY) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of €2.23 versus a price of €18.78, about −88% upside (overvalued).
What is the fair value of REMEDY?
Our model-based fair value for Remedy Entertainment Oyj is €2.23 (as of Sep 27, 2026), built from audited fundamentals. The current price: €18.78.
What is the quality score of REMEDY?
Remedy Entertainment Oyj has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Remedy Entertainment Oyj (REMEDY)?
Our model-based price target is the fair value of €2.23 (as of Sep 27, 2026) from 10 valuation models. Cautious scenario €1.24, optimistic scenario €4.05. It is a calculation from audited fundamentals, not an analyst target.
What is the Remedy Entertainment Oyj stock forecast for 2026?
Our models put fair value at €2.23, about −88% upside versus a price of €18.78 (overvalued). Cautious scenario €1.24, optimistic scenario €4.05. The calculation is refreshed regularly with new filings.
What is the revenue of Remedy Entertainment Oyj (REMEDY)?
Remedy Entertainment Oyj reported trailing-twelve-month revenue of about €59.3M (latest available figure, as of Sep 27, 2026).
What growth is priced into Remedy Entertainment Oyj (REMEDY)?
For today's price to be fair in a discounted-cash-flow model, Remedy Entertainment Oyj would have to grow free cash flow by more than 80 % per year for five years (discount rate 13.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.7 % per year. As of Sep 27, 2026.
What discount rate (WACC) does the fair value of REMEDY use?
Our models discount Remedy Entertainment Oyj at 13.0 %: a base by market capitalisation (micro), damped by beta 1.05, country premium for Finland. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Remedy Entertainment Oyj that is more than 80 % per year a year over ten years, using the same discount rate (13.0 %) and the same formula as our fair value.
How much growth has Remedy Entertainment Oyj (REMEDY) delivered so far?
Over the past 5 years revenue at Remedy Entertainment Oyj grew +7.7 % a year. The price currently implies more than 80 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Remedy Entertainment Oyj (REMEDY) growing?
The median revenue growth in the sector is +2.0 % a year. That is the yardstick for the growth priced into Remedy Entertainment Oyj (more than 80 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Remedy Entertainment Oyj (REMEDY)?
The free-cash-flow yield on the price is 0.26 %: that much free cash flow Remedy Entertainment Oyj produces per unit of market value. When it exceeds the discount rate of our models (13.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Remedy Entertainment Oyj (REMEDY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Remedy Entertainment Oyj it is €2.23 per share (as of Sep 27, 2026), against a price of €18.78. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is Remedy Entertainment Oyj stock overvalued or undervalued in 2026?
As of Sep 27, 2026, REMEDY trades above its calculated fair value: price €18.78, fair value €2.23, a gap of about −88% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of REMEDY?
No. The price is what the market pays today (€18.78); the fair value is what the company's own numbers justify (€2.23). For Remedy Entertainment Oyj the two are €16.55 per share apart. That gap is exactly why we show both numbers side by side.
How much is Remedy Entertainment Oyj worth?
The market values Remedy Entertainment Oyj at about €256M (market capitalisation, as of Sep 27, 2026). Per share that is €18.78; our models calculate a fair value of €2.23 per share.
What do the bullish and bearish scenarios say about REMEDY?
Our models span a range for Remedy Entertainment Oyj: cautious scenario €1.24, base €2.23, optimistic €4.05 per share (as of Sep 27, 2026, price €18.78). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Remedy Entertainment Oyj (REMEDY)?
Balance-sheet figures for Remedy Entertainment Oyj (as of Sep 27, 2026): return on equity −20.6%, debt of 0.26 per unit of equity. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is REMEDY from its 52-week high?
Remedy Entertainment Oyj trades at €18.78, about 6% below its 52-week high of €19.88 and 69% above the low of €11.10 (as of Sep 29, 2026). Distance from the high says nothing about value: that is what the fair value of €2.23 is for.
Which stocks are comparable to Remedy Entertainment Oyj?
From the same area (Communication Services) we also value Konami Group, NetEase, Inc, Take-Two Interactive Software, Inc, Roblox Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Remedy Entertainment Oyj stock attractive at the current price?
The data as of Sep 27, 2026: price €18.78, calculated fair value €2.23 (−88%), Quality Score 51/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of REMEDY calculated?
We run Remedy Entertainment Oyj through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €2.23, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.8 % above its aggregate fair value. Remedy Entertainment Oyj itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Remedy Entertainment Oyj (REMEDY)?
The closing price on Sep 29, 2026 was €18.78. Our model-based fair value is €2.23, about −88% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Remedy Entertainment Oyj right now?
The price sits above even our optimistic bull case (€4.05). The favourable scenario is already priced in. The model range is unusually wide (€1.24 to €4.05). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (51/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Remedy Entertainment Oyj
How large is the market capitalisation of Remedy Entertainment Oyj (REMEDY)?
The market capitalisation of Remedy Entertainment Oyj is €256M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Remedy Entertainment Oyj (REMEDY)?
The price-to-sales ratio of Remedy Entertainment Oyj is 3.44 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Remedy Entertainment Oyj (REMEDY)?
Earnings per share at Remedy Entertainment Oyj are €−0.9600. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Remedy Entertainment Oyj (REMEDY)?
The net margin of Remedy Entertainment Oyj is −21.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Remedy Entertainment Oyj (REMEDY)?
The return on equity (ROE) of Remedy Entertainment Oyj is −20.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Remedy Entertainment Oyj (REMEDY)?
On an EBIT basis the return on assets of Remedy Entertainment Oyj is −6.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Remedy Entertainment Oyj (REMEDY)?
The operating margin of Remedy Entertainment Oyj is 7.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Remedy Entertainment Oyj (REMEDY)?
Revenue at Remedy Entertainment Oyj is growing −1.9% versus a year earlier (3y avg +10.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Remedy Entertainment Oyj (REMEDY)?
Earnings per share at Remedy Entertainment Oyj are growing −12.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Remedy Entertainment Oyj (REMEDY) carry?
The net debt of Remedy Entertainment Oyj is €8.6M (fiscal year 2025, ≈ 13.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Remedy Entertainment Oyj in the live analysis
One click puts Remedy Entertainment Oyj on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
